Skip to content
Baltimore News Journal – Lifestyle
Author:
Lexaria Bioscience Corp.
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
April 21, 2026
Lexaria’s New Animal Study Aims to Expand Valuable Intellectual Property
April 15, 2026
Lexaria Applauds Eli Lilly’s Foundayo(TM) Drug Approval
April 7, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
April 1, 2026
Lexaria’s Robust Patent Portfolio Continues to Grow
March 26, 2026
←
Previous Page
1
2